Arthrex's knee innovation named one of 2018's Top 10 Sports Medicine Technologies
Anterior cruciate ligament tear or sprain is one of the most commonly presented knee injuries. It’s widely seen in high-demand sports stars, and in years gone by was regarded as a career-ending injury. Famous football players like Zlatan Ibrohimovich, Theo Walcott and Ruud van Nistelrooy have all suffered ACL injuries, and made good recoveries thanks to ever-improving patient treatment options - led in part by our client, the market leaders Arthrex.
The cruciate ligaments cross paths at the back of the knee joint, controlling the back and forth motion of the knee. The anterior cruciate stops the tibia from sliding out in front of the femur, and also provides stability in the joint. ACL injuries are commonly caused by stopping suddenly when running, changing direction rapidly, landing badly from a jump and from direct impact, such as a tackle in football. Such an injury will often result in a complete tear of the ACE, which can be extremely painful and debilitating for patients. In the past, treatment options have been fairly basic and invasive, leading to difficult and time-consuming recovery for patients, so it was Arthrex to the rescue! The Minimally Invasive Quad Tendon Harvest System was developed by the engineering and consulting teams of this global orthopaedic medical equipment supplier. The development was led by Senior Group Product Manager Jake Jolly, Engineering Manager Tara Swanlaw and Senior Product Engineer Zach Ingwer. In July 2018, industry news source Orthopedics This Week named the Minimally Invasive Quad Tendon Harvest System as one of the "Ten Best Sports Medicine Technologies of 2018." This annual award honors inventors, engineering teams, physicians and companies who’ve created the most innovative, enduring and practical products to treat injured athletes.
Arthrex’s innovative technology is highlighted as “giving surgeons doing cruciate ligament reconstruction a new, faster and less invasive way to safely harvest a graft of a desired length and diameter through a smaller incision.” So how does it work? Based on published anatomic studies, the System allows surgeons to safely graft a section of tissue of a specified length and width without the need to create a large, invasive incision. A graft is taken from the quadricep tendon on top of the knee joint - this tendon is ideal for use in ACL reconstruction because of its predictably large diameter and preferable stiffness profile during recovery time. These factors combine to improve patient recovery drastically. Dr. DeBerardino, orthopaedic surgeon with the San Antonio Orthopaedic Group, said this combination of technologies is one of the best developments in orthopedics in the last decade. “Now we can use the same state-of-the-art cortical suspensory TightRope® fixation and apply it to a quad tendon which you could not do before without the advent of the FiberTag device,” he added. Here at Dynamic Medical we like to see leading companies receiving recognition for their innovative works, and we’d like to congratulate the team at Arthrex for this remarkable